Orasis Pharmaceuticals Concludes Phase 3 Clinical Trials for Presbyopia Candidate
Herzliya, Israel, March 15, 2022 – Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on developing a unique eye drop to improve near vision for people with presbyopia, today announced…